Why does the latest pharmacovigilance data not reflect clinical experience with dydrogesterone?

Emre Pabuccu
, Angela Aguilar
, Roberto De Azevedo Antunes
, Eran Gefen
, Lee P. Shulman

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	hoaf030
Journal	Human Reproduction Open
Volume	2025
Issue number	3
DOIs	https://doi.org/10.1093/hropen/hoaf030
State	Published - 2025
Externally published	Yes

ASJC Scopus subject areas

Reproductive Medicine
Embryology
Obstetrics and Gynecology

Access to Document

10.1093/hropen/hoaf030

Other files and links

Link to publication in Scopus

Cite this

@article{87c9fd9e64624ee9a51a95447d70b4b1,

title = "Why does the latest pharmacovigilance data not reflect clinical experience with dydrogesterone?",

author = "Emre Pabuccu and Angela Aguilar and \{De Azevedo Antunes\}, Roberto and Eran Gefen and Shulman, \{Lee P.\}",

year = "2025",

doi = "10.1093/hropen/hoaf030",

language = "English",

volume = "2025",

journal = "Human Reproduction Open",

issn = "2399-3529",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Why does the latest pharmacovigilance data not reflect clinical experience with dydrogesterone?

AU - Pabuccu, Emre

AU - Aguilar, Angela

AU - De Azevedo Antunes, Roberto

AU - Gefen, Eran

AU - Shulman, Lee P.

PY - 2025

Y1 - 2025

UR - https://www.scopus.com/pages/publications/105008413313

U2 - 10.1093/hropen/hoaf030

DO - 10.1093/hropen/hoaf030

M3 - Letter

C2 - 40497085

AN - SCOPUS:105008413313

SN - 2399-3529

VL - 2025

JO - Human Reproduction Open

JF - Human Reproduction Open

IS - 3

M1 - hoaf030

ER -